1. Home
  2. RGP vs RZLT Comparison

RGP vs RZLT Comparison

Compare RGP & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$5.27

Market Cap

146.3M

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.70

Market Cap

187.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
RZLT
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.3M
187.3M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
RGP
RZLT
Price
$5.27
$2.70
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.00
$12.33
AVG Volume (30 Days)
306.7K
14.6M
Earning Date
01-07-2026
02-11-2026
Dividend Yield
5.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$534,625,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$1.07
52 Week High
$9.96
$11.46

Technical Indicators

Market Signals
Indicator
RGP
RZLT
Relative Strength Index (RSI) 63.24 31.54
Support Level $5.14 $1.78
Resistance Level $5.36 $2.82
Average True Range (ATR) 0.15 0.49
MACD 0.00 -0.20
Stochastic Oscillator 84.03 15.55

Price Performance

Historical Comparison
RGP
RZLT

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: